Jianbo Xu

4.9k citations
99 papers · 3.5k indexed · 3 hit papers · h-index 28
Topics
Gastric Cancer Management and Outcomes (18 papers)RNA modifications and cancer (12 papers)Colorectal Cancer Surgical Treatments (9 papers)

In The Last Decade

Jianbo Xu

88 papers receiving 3.5k citations

Hit Papers

A peptide encoded by circular form of LINC-PINT suppresse...2014202620182022201820172014100200300400500

Peers

Jianbo Xu
Comparison fields: 5 of 139
  • Oncology 1.4k
  • Molecular Biology 1.3k
  • Cancer Research 1.1k
  • Pulmonary and Respiratory Medicine 649
  • Surgery 632
Replace Bin Xu with:
Bin Xu China
Yukiharu Hiyoshi Japan
Atsushi Arakawa Japan
Alan R. Schned United States
Zhihong Zhang China
Shiro Iwagami Japan
Masataka Ikeda Japan
Ming‐Huang Chen Taiwan
Suee Lee South Korea
Gang Jin China
Jianbo Xu relative to Bin Xu China Bin Xu's profile →
Citations per field
00.5×1.5×
Bin Xu · 1×
Citations per year

Countries citing papers authored by Jianbo Xu

Since Specialization
Citations

This map shows the geographic impact of Jianbo Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianbo Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianbo Xu more than expected).

Fields of papers citing papers by Jianbo Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianbo Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianbo Xu. The network helps show where Jianbo Xu may publish in the future.

Co-authorship network of co-authors of Jianbo Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianbo Xu. A scholar is included among the top collaborators of Jianbo Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianbo Xu. Jianbo Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 1
5 1
6 10
7 0
8 6
9 4
10 3
11 36
12 13
13 91
14 67
15 40
16 148
17 17
18 42
19 14
20 61

About Jianbo Xu

Jianbo Xu is a scholar working on Oncology, Cancer Research and Gastroenterology, having authored 99 papers that have together received 3.5k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (18 papers), RNA modifications and cancer (12 papers) and Colorectal Cancer Surgical Treatments (9 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.4k citations) and Pulmonary and Respiratory Medicine (649 citations). Jianbo Xu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yulong He, Chuangqi Chen, Guanghua Li, Kaiyu Sun, Shirong Cai, Yujie Yuan, Jianjun Peng, Shuling Chen, Shirong Cai and Jianhui Chen. Their work appears in journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026